Andrew Spaventa is Chief Executive Officer of Singular Genomics Systems, Inc.. Currently has a direct ownership of 325 shares of OMIC, which is worth approximately $6,961. The most recent transaction as insider was on Nov 12, 2024, when has been sold 1,212 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 325
0% 3M change
96.67% 12M change
Total Value Held $6,961

Andrew Spaventa Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 12 2024
SELL
Bona fide gift
-
1,212 Reduced 78.85%
325 Common Stock
Nov 12 2024
SELL
Open market or private sale
$15,672 $22.55 p/Share
695 Reduced 31.14%
1,537 Common Stock
Nov 12 2024
BUY
Exercise of conversion of derivative security
-
1,907 Added 46.07%
2,232 Common Stock
Sep 15 2024
SELL
Bona fide gift
-
312 Reduced 48.98%
325 Common Stock
Sep 15 2024
SELL
Open market or private sale
$2,166 $12.38 p/Share
175 Reduced 21.55%
637 Common Stock
Sep 15 2024
BUY
Exercise of conversion of derivative security
-
487 Added 37.49%
812 Common Stock
Aug 12 2024
SELL
Payment of exercise price or tax liability
$4,848 $7.12 p/Share
681 Reduced 30.52%
1,550 Common Stock
Aug 12 2024
SELL
Bona fide gift
-
1,225 Reduced 79.03%
325 Common Stock
Aug 12 2024
BUY
Exercise of conversion of derivative security
-
1,906 Added 46.07%
2,231 Common Stock
Jun 15 2024
SELL
Bona fide gift
-
14,584 Reduced 59.89%
9,766 Common Stock
Jun 15 2024
BUY
Exercise of conversion of derivative security
-
14,584 Added 37.46%
24,350 Common Stock
May 12 2024
SELL
Bona fide gift
-
57,188 Reduced 85.41%
9,766 Common Stock
May 12 2024
BUY
Exercise of conversion of derivative security
-
57,188 Added 46.07%
66,954 Common Stock
Mar 15 2024
SELL
Bona fide gift
-
14,583 Reduced 59.89%
9,766 Common Stock
Mar 15 2024
BUY
Exercise of conversion of derivative security
-
14,583 Added 37.46%
24,349 Common Stock
Dec 15 2023
SELL
Bona fide gift
-
14,583 Reduced 59.89%
9,766 Common Stock
Dec 15 2023
BUY
Exercise of conversion of derivative security
-
14,583 Added 37.46%
24,349 Common Stock
Sep 15 2023
SELL
Bona fide gift
-
14,584 Reduced 59.89%
9,766 Common Stock
Sep 15 2023
BUY
Exercise of conversion of derivative security
-
14,584 Added 37.46%
24,350 Common Stock
Jun 15 2023
SELL
Bona fide gift
-
14,583 Reduced 59.89%
9,766 Common Stock
Jun 15 2023
BUY
Exercise of conversion of derivative security
-
14,583 Added 37.46%
24,349 Common Stock
Mar 24 2022
BUY
Other acquisition or disposition
-
9,766 Added 50.0%
9,766 Common Stock
AS

Andrew Spaventa

Chief Executive Officer
La Jolla, CA

Track Institutional and Insider Activities on OMIC

Follow Singular Genomics Systems, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells OMIC shares.

Notify only if

Insider Trading

Get notified when an Singular Genomics Systems, Inc. insider buys or sells OMIC shares.

Notify only if

News

Receive news related to Singular Genomics Systems, Inc.

Track Activities on OMIC